CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label Trial of STRIBILD™ (Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate) for ARV-naïve HIV-2 Infected Adults in Dakar, Senegal

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02180438
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:51.969347+00:00
Published At: 2018-05-08T00:00:00+00:00
Record Updated At: 2018-07-26
Results Posted At: 2018-05-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["HIV-2 Infection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-07-26"
protocolSection.identificationModule.nctId: "NCT02180438"
protocolSection.identificationModule.officialTitle: "An Open Label Trial of STRIBILD\u2122 (Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate) for ARV-na\u00efve HIV-2 Infected Adults in Dakar, Senegal"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-05-08"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.